<?xml version="1.0" encoding="UTF-8"?><!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com --><!-- Created: Fri Nov 13 21:17:56 UTC 2026 --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:common="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001773195</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>5</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001661059</issuerCik>
        <issuerName>NextCure, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>65343E207</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <common:street1>9000 VIRGINIA MANOR ROAD, SUITE 200</common:street1>
          <common:city>BELTSVILLE</common:city>
          <common:stateOrCountry>MD</common:stateOrCountry>
          <common:zipCode>20705</common:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Affinity Asset Advisors, LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>475626.00</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>475626.00</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>475626.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.99</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Michael Cho</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>475626.00</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>475626.00</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>475626.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.99</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>NextCure, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>9000 Virginia Manor Road, Suite 200 Beltsville, MD 20705</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Affinity Asset Advisors, LLC
Michael Cho</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>450 Park Avenue
Suite 1403
New York, NY 10022</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Affinity Asset Advisors, LLC is a Delaware limited liability company, and Michael Cho is an individual and is a citizen of the United States.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The securities reported herein are directly held by Affinity Healthcare Fund, LP (the "Fund").  Affinity Asset Advisors, LLC (the "Adviser") is the investment manager of the Fund and exercises voting and investment power over the securities held directly by the Fund reported herein pursuant to an investment management agreement between the Adviser, the Fund, and the general partner of the Fund.  The Adviser may be deemed to beneficially own the securities reported herein held by the Fund by virtue of its position as investment manager of the Fund.  Michael Cho, the managing member of the Adviser, may be deemed a beneficial owner of the securities reported herein held by the Fund.

As of September 30, 2026, the Adviser and Mr. Cho (collectively, the "Reporting Persons") beneficially own 475,626 shares of common stock, $0.001 par value per share ("Common Stock"), of NextCure, Inc. (the "Issuer"), which amount includes 183,666 shares of Common Stock issuable upon exercise of warrants (the "Warrants").  The Warrants are all subject to a beneficial ownership limitation of 9.99% of the number of shares of Common Stock of the Issuer outstanding immediately after giving effect to the issuance of the shares issuable upon exercise of the Warrants (the "Beneficial Ownership Limitation").</amountBeneficiallyOwned>
        <classPercent>As of September 30, 2026, the Reporting Persons beneficially own approximately 9.99% of the Common Stock outstanding.

The percentages disclosed above are based on 4,761,025 shares of Common Stock of the Issuer outstanding as of August 15, 2026, consisting of (a) the 4,577,359 shares of Common Stock of the Issuer outstanding as of August 15, 2026, as set forth in the Issuer's Form S-4 filed with the Securities and Exchange Commission (the "SEC") on October 1, 2026, and (b) 183,666 shares of Common Stock issuable upon the exercise of the Warrants, after giving effect to the Beneficial Ownership Limitation.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>As of September 30, 2026, the Reporting Persons have sole power to vote or to direct the vote of 475,626 shares of Common Stock, which amount includes 183,666 shares of Common Stock issuable upon the exercise of warrants after giving effect to the Beneficial Ownership Limitation.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>As of September 30, 2026, the Reporting Persons have shared power to vote or to direct the vote of 0 shares of Common Stock.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>As of September 30, 2026, the Reporting Persons have sole power to dispose or to direct the disposition of 475,626 shares of Common Stock, which amount includes 183,666 shares of Common Stock issuable upon the exercise of warrants after giving effect to the Beneficial Ownership Limitation.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>As of September 30, 2026, the Reporting Persons have shared power to dispose or to direct the disposition of 0 shares of Common Stock.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Affinity Asset Advisors, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Andrew Weinstein</signature>
        <title>Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer</title>
        <date>11/13/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Michael Cho</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Michael Cho</signature>
        <title>Michael Cho, Self</title>
        <date>11/13/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
